As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

With the “gym,” Insilico is now targeting other biotech and pharmaceutical companies, offering to train new AI models for ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Under the terms of the collaboration, Iktos will apply its generative AI and AI-orchestrated robotics platform to design, ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

NVIDIA and its partners have, over recent days, unveiled a wave of new AI hardware and collaborations, from Blackwell-based ...

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...